Dr Bristi Basu is an academic consultant in medical oncology, specialising in experimental cancer therapeutics in the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. She trained in Medicine at Oxford University (Prosser Exhibitions) before undertaking clinical speciality training in Medical Oncology at Cambridge. During this time, she completed a PhD in cancer cell biology and drug discovery at the University of Cambridge as the Cancer Research UK Gordon Hamilton-Fairley Clinical Research Training Fellow. She has worked with experimental cancer therapy agents in several early phase trials, specialising in hepato-pancreatico-biliary malignancies, both at Cambridge and previously as a Clinical Research Fellow at the Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Surrey. She sits on the UK NCRI Upper GI Clinical Studies Group contributing to the Hepatobiliary subgroup and works in the UK NIHR CRN Early Phase Cancer Studies Specialty Group as Eastern Lead. She has worked as a chief and principal investigator on several pancreatic cancer trials and is research lead for the Pancreatic Cancer Network Cancer Group within the East of England Strategic Clinical Network.